Search

Nanofibers (NFs) offer an alternative option for the treatment of Alzheimer's disease (AD) by addressing unmet clinical problems. In this study, anti‐AD drugs, donepezil (DO) and curcumin (CUR), are loaded in polylactic acid/polycaprolactone NFs. The effect of fiber diameter on drug release behavior is mainly observed, and the successful loading of DO and CUR to NFs is demonstrated. The tensile strength of DO/CUR‐loaded NFs (DNFs) with lower fiber diameter is found to be higher. The working temperature is increased by the decrease of glass transition temperature and increase of the melting temperature after loading drugs. Furthermore, the increase in the percentage of swelling and decrease in the degradation rate for NFs are observed due to the increase of fiber diameter. Encapsulation efficiency and burst release percentages for DNFs are augmented by the increase of fiber diameter. Nevertheless, DNFs exhibit a sustained drug release manner over 2 weeks. NFs do not demonstrate a toxic effect on L929 (mouse fibroblast) cells, and additionally, they promote cell proliferation. Considering all these results, it is proven that the fiber diameter affects all characteristic features of NFs, and DNFs lead to a new and promising drug delivery system for the treatment of AD. [ABSTRACT FROM AUTHOR]

A composite nanofiber composed of three polymers, namely polyvinyl alcohol/polyvinyl pyrrolidone/polyethylene oxide, is produced. The experiments are constructed using three design of experiment techniques, Taguchi L9, Taguchi L27, and Screening method. The experiments are verified using the analysis of variance (ANOVA) method and later a mathematical model is developed using the regression method. The impact of electrospun processing parameters, namely applied voltage, flow rate, and working distance, on nanofibers' diameter is measured. The working distance is a significant factor in controlling the size of the fiber diameter, while the applied voltage has the lowest effect on it. As a result of the regression equation, a Genetic algorithm is used to find the optimum variables for the required fiber diameter, which is 156 nm for flow rate = 0.001 mL h−1, voltage = 30 kV, and distance = 200 mm with a 3% difference from the experimental fiber diameter. [ABSTRACT FROM AUTHOR]

The combination of oral antidiabetic drugs, pioglitazone, metformin, and glibenclamide, which also exhibit the strongest anti-inflammatory action among oral antidiabetic drugs, were loaded into chitosan/gelatin/polycaprolactone (PCL) by electrospinning and polyvinyl pyrrolidone (PVP)/PCL composite nanofibrous scaffolds by pressurized gyration to compare the diabetic wound healing effect. The combination therapies significantly accelerated diabetic wound healing in type-1 diabetic rats and organized densely packed collagen fibers in the dermis, it also showed better regeneration of the dermis and epidermis than single drug-loaded scaffolds with less inflammatory cell infiltration and edema. The formation of the hair follicles started in 14 days only in the combination therapy and lower proinflammatory cytokine levels were observed compared to single drug-loaded treatment groups. The combination therapy increased the wettability and hydrophilicity of scaffolds, demonstrated sustained drug release over 14 days, has high tensile strength and suitable cytocompatibility on L929 (mouse fibroblast) cell and created a suitable area for the proliferation of fibroblast cells. Consequently, the application of metformin and pioglitazone-loaded chitosan/gelatin/PCL nanofibrous scaffolds to a diabetic wound area offer high bioavailability, fewer systemic side effects, and reduced frequency of dosage and amount of drug. Unlabelled Image • Metformin, pioglitazone, and glibenclamide were loaded into scaffolds by ES and PG. • The combination therapies (CT) accelerated diabetic wound healing on type-1 diabetic rats. • CT showed better regeneration and lower TNF-α and NF-κB levels than single drug therapies. • The formation of the hair follicles started in 14 days only in CT. • CT has good cytocompatibility with L929 cells and ideal area for the proliferation. [ABSTRACT FROM AUTHOR]

Progesterone-loaded poly(lactic) acid fibrous polymeric patches were produced using electrospinning and pressurized gyration for intra-vaginal application to prevent preterm birth. The patches were intravaginally inserted into rats in the final week of their pregnancy, equivalent to the third trimester of human pregnancy. Maintenance tocolysis with progesterone-loaded patches was elucidated by recording the contractile response of uterine smooth muscle to noradrenaline in pregnant rats. Both progesterone-loaded patches indicated similar results from release and thermal studies, however, patches obtained by electrospinning had smaller average diameters and more uniform dispersion compared to pressurized gyration. Patches obtained by pressurized gyration had better results in production yield and tensile strength than electrospinning; thereby pressurized gyration is better suited for scaled-up production. The patches did not affect cell attachment, viability, and proliferation on Vero cells negatively. Consequently, progesterone-loaded patches are a novel and successful treatment strategy for preventing preterm birth. [ABSTRACT FROM AUTHOR]

• The characterization of electrospun Achillea lycaonica-loaded PLA fibers was described. • SEM, FTIR, DSC, tensile, drug release and cell culture tests of fibers were performed. • Achillea lycaonica-loaded fibers increased the viability of NIH/3T3 cells. • Samples have proper tensile strength and exhibit controlled release. • Achillea lycaonica-loaded fibers do not have a risk of melting on the human body. The use of natural compounds such as biocompatible and non-toxic plant extracts, without undesired side effects, in tissue engineering applications, is highly preferred compared to chemical drugs. In this study, the characterization and performance of electrospun Achillea lycaonica-loaded (0.125, 0.250 and 0.500, wt%) poly(lactic acid) (PLA) (8%, w/v) nanofibrous mats for skin tissue engineering were investigated. SEM, FTIR, DSC, and tensile strength test of the electrospun nanofibers have been investigated. Drug releasing test and cell culture study were also carried out. Achillea lycaonica-loaded nanofibrous mats in 0.250 (wt%) and 0.500 (wt%) demonstrated excellent cell compatibility and increased the viability of NIH/3T3 (mouse embryo fibroblast) cells within 72 h. According to the results, Achillea lycaonica-loaded PLA nanofibers have proper tensile strength and controlled release. The working temperature range enlarged for the composites having higher plant extract content. Consequently, Achillea lycaonica-loaded nanofibrous mats have a great potential in skin tissue engineering applications. [ABSTRACT FROM AUTHOR]

In this study, Teucrium polium (TP) methanolic extract, which has antidiabetic activity and protects the β-cells of the pancreas, was loaded in polyethylene oxide/sodium alginate nanofibers by electrospinning and administered sublingually to evaluate their effectiveness in type-2 diabetes mellitus (T2DM) by cell culture and in vivo studies. The gene expressions of insulin, glucokinase, GLUT-1, and GLUT-2 improved in TP-loaded nanofibers (TPF) on human beta cells 1.1B4 and rat beta cells BRIN-BD11. Fast-dissolving (<120 s) sublingual TPF exhibited better sustainable anti-diabetic activity than the suspension form, even in the twenty times lower dosage in streptozotocin/nicotinamide-induced T2DM rats. The levels of GLP-1, GLUT-2, SGLT-2, PPAR-γ, insulin, and tumor necrosis factor-alpha were improved. TP and TPF treatments ameliorated morphological changes in the liver, pancreas, and kidney. The fiber diameter increased, tensile strength decreased, and the working temperature range enlarged by loading TP in fibers. Thus, TPF has proven to be a novel supportive treatment approach for T2DM with the features of being non-toxic, easy to use, and effective. [Display omitted] • Teucrium polium (TP) extract was loaded in nanofibers (TPF) by electrospinning. • Sublingually administered TPF showed ultra-fast drug release on diabetic rats. • TPF showed antidiabetic activity in streptozotocin/nicotinamide-induced T2DM. • TPF improved the expressions of GLP-1, GLUT-2, PPAR-γ, Insulin, and TNF-α on rats. • The regeneration effect of TPF on liver, pancreas, and kidney was shown. [ABSTRACT FROM AUTHOR]